ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 193 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q2 2020. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $18,000 | +20.0% | 221 | +14.5% | 0.00% | 0.0% |
Q2 2020 | $15,000 | -16.7% | 193 | -51.3% | 0.00% | -50.0% |
Q1 2020 | $18,000 | +28.6% | 396 | +21.5% | 0.00% | 0.0% |
Q4 2019 | $14,000 | -85.1% | 326 | -85.1% | 0.00% | -86.7% |
Q3 2019 | $94,000 | -17.5% | 2,191 | +21.7% | 0.03% | -25.0% |
Q2 2019 | $114,000 | – | 1,801 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Iguana Healthcare Management, LLC | 75,000 | $4,658,000 | 2.63% |
COLUMBIA WANGER ASSET MANAGEMENT LLC | 1,364,434 | $84,745,000 | 1.21% |
CAPITAL INTERNATIONAL LTD /CA/ | 259,700 | $16,130,000 | 1.07% |
Aureus Asset Management, LLC | 65,670 | $4,079,000 | 0.69% |
Capital International Sarl | 124,320 | $7,722,000 | 0.67% |
CAPITAL GUARDIAN TRUST CO | 512,430 | $31,827,000 | 0.58% |
ROCKEFELLER FINANCIAL SERVICES INC | 408,379 | $25,365,000 | 0.50% |
Rock Springs Capital Management LP | 160,500 | $9,969,000 | 0.50% |
Hood River Capital Management LLC | 112,296 | $6,975,000 | 0.48% |
Capital International, Inc./CA/ | 52,700 | $3,273,000 | 0.47% |